A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase
- PMID: 21441930
- DOI: 10.1038/ng.795
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase
Abstract
The development of a quantitative understanding of viral evolution and the fitness landscape in HIV-1 drug resistance is a formidable challenge given the large number of available drugs and drug resistance mutations. We analyzed a dataset measuring the in vitro fitness of 70,081 virus samples isolated from HIV-1 subtype B infected individuals undergoing routine drug resistance testing. We assayed virus samples for in vitro replicative capacity in the absence of drugs as well as in the presence of 15 individual drugs. We employed a generalized kernel ridge regression to estimate main fitness effects and epistatic interactions of 1,859 single amino acid variants found within the HIV-1 protease and reverse transcriptase sequences. Models including epistatic interactions predict an average of 54.8% of the variance in replicative capacity across the 16 different environments and substantially outperform models based on main fitness effects only. We find that the fitness landscape of HIV-1 protease and reverse transcriptase is characterized by strong epistasis.
Comment in
-
High-throughput identification of genetic interactions in HIV-1.Nat Genet. 2011 May;43(5):398-400. doi: 10.1038/ng.820. Nat Genet. 2011. PMID: 21522176 No abstract available.
Similar articles
-
Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.Retrovirology. 2014 Nov 29;11:105. doi: 10.1186/s12977-014-0105-9. Retrovirology. 2014. PMID: 25575025 Free PMC article.
-
Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease.PLoS Genet. 2020 Oct 21;16(10):e1009009. doi: 10.1371/journal.pgen.1009009. eCollection 2020 Oct. PLoS Genet. 2020. PMID: 33085662 Free PMC article.
-
Evidence for positive epistasis in HIV-1.Science. 2004 Nov 26;306(5701):1547-50. doi: 10.1126/science.1101786. Science. 2004. PMID: 15567861
-
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.AIDS Rev. 2003 Jan-Mar;5(1):25-35. AIDS Rev. 2003. PMID: 12875105 Review.
-
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.AIDS. 2007 Jan 11;21(2):215-23. doi: 10.1097/QAD.0b013e328011e691. AIDS. 2007. PMID: 17197813 Free PMC article. Review.
Cited by
-
Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132. Viruses. 2012. PMID: 23202519 Free PMC article. Review.
-
Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance.Theor Biol Med Model. 2012 Mar 19;9:9. doi: 10.1186/1742-4682-9-9. Theor Biol Med Model. 2012. PMID: 22429506 Free PMC article.
-
Large-effect flowering time mutations reveal conditionally adaptive paths through fitness landscapes in Arabidopsis thaliana.Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17890-17899. doi: 10.1073/pnas.1902731116. Epub 2019 Aug 16. Proc Natl Acad Sci U S A. 2019. PMID: 31420516 Free PMC article.
-
Epistasis and entrenchment of drug resistance in HIV-1 subtype B.Elife. 2019 Oct 8;8:e50524. doi: 10.7554/eLife.50524. Elife. 2019. PMID: 31591964 Free PMC article.
-
Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV.PLoS Genet. 2018 Jun 28;14(6):e1007420. doi: 10.1371/journal.pgen.1007420. eCollection 2018 Jun. PLoS Genet. 2018. PMID: 29953449 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
